MARIUS PHARMACEUTICALS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CROSSROADS STRATEGIES, LLC	—	3

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	2
SENATE	2
Executive Office of the President (EOP)	1
Office of Management & Budget (OMB)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	3

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 7623118th Congress

Telehealth Modernization Act of 2024

2024 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC

Cited source text and reported amounts

Issues related to telehealth and telemedicine; H.R.7623, Telehealth Modernization Act of 2024.

Client expense: — · Firm income: $30,000

Matched citations: H.R.7623

H.R. 7623118th Congress

Telehealth Modernization Act of 2024

2024 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC

Cited source text and reported amounts

Issues related to telehealth and telemedicine; H.R.7623, Telehealth Modernization Act of 2024.

Client expense: — · Firm income: $10,000

Matched citations: H.R.7623

H.R. 7623118th Congress

Telehealth Modernization Act of 2024

2024 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC

Cited source text and reported amounts

Issues related to telehealth and telemedicine; H.R.7623, Telehealth Modernization Act of 2024.

Client expense: — · Firm income: —

Matched citations: H.R.7623

MARIUS PHARMACEUTICALS — Lobbying Disclosure | Poliscope